Levalbuterol
- Product NDC
- 68788-6777
- 11-digit product format
- 687886777
- Labeler code
- 68788
- Product ID
- 68788-6777_a9959bc1-e5e6-46e7-be8d-bd2865b3a05e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levalbuterol
- Dosage form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- ANDA090297
- Marketing category
- ANDA
- Marketing start
- 2016-10-24
- Marketing end
- 0000-00-00
- Substance
- LEVALBUTEROL HYDROCHLORIDE
- Active strength
- 1 mg/3mL
- Pharmacologic classes
- Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68788-6777 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 68788-6777 | 68788-6777-2 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090297-001 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE | SOLUTION / INHALATION | AN | RS | 2013-04-26 |
| A090297-002 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE | SOLUTION / INHALATION | AN | RS | 2013-04-26 |
| A090297-003 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE | SOLUTION / INHALATION | AN | RS | 2013-04-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090297-001 | AN |
| A090297-002 | AN |
| A090297-003 | AN |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090297-001 | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE | SOLUTION / INHALATION | AN | RS | 2013-04-26 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090297-002 | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE | SOLUTION / INHALATION | AN | RS | 2013-04-26 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090297-003 | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE | SOLUTION / INHALATION | AN | RS | 2013-04-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090297-001 | AN | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090297-002 | AN | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A090297-003 | AN | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levalbuterol | LEVALBUTEROL | Proficient Rx LP | 97699821-81f8-4623-8504-e479c0f4b183 | 2019-11-01 | Warnings, Adverse reactions | 090297 ANDA090297 |
| Levalbuterol | LEVALBUTEROL | Teva Pharmaceuticals USA, Inc. | f3ce78d9-e923-400e-b3cd-3e6124ac7f6d | 2019-01-31 | Warnings, Adverse reactions | 090297 ANDA090297 |